Lobbying client

BACTERIOSCAN, INC.

Develops and manufactures medical diagnostic devices and tests for infectious diseases.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
19
Filed by
2
Reported in-house
—
Reported by firms
$330,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2020 to 2022

Filings

19 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2022
FOREST HILL CONSULTING — reported
4th Quarter - Report (No Activity)
4th Quarter 2021
FOREST HILL CONSULTING — reported
4th Quarter - Termination
4th Quarter 2021
S-3 GROUP — reported
3rd Quarter - Report
3rd Quarter 2021
S-3 GROUP — reported
3rd Quarter - Report
3rd Quarter 2021
FOREST HILL CONSULTING — reported
2nd Quarter - Report
2nd Quarter 2021
FOREST HILL CONSULTING $30,000 reported
2nd Quarter - Report
2nd Quarter 2021
S-3 GROUP — reported
1st Quarter - Report
1st Quarter 2021
FOREST HILL CONSULTING $30,000 reported
1st Quarter - Report
1st Quarter 2021
S-3 GROUP — reported
4th Quarter - Report
4th Quarter 2020
S-3 GROUP — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
FOREST HILL CONSULTING 9 $180,000
S-3 GROUP 8 $150,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 17

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 6074 116th 10
S. 3548 116th 8
H.R. 6201 116th 8

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.